Metabolic Health, Endometrial Cancer, and Black Women: New Review Highlights Critical Clinical and Equity Gaps 

endometrial cancer and metabolic health in black women

Endometrial cancer is the fourth most common cancer for women in the United States and a leading cause of cancer-related deaths. According to the American Cancer Society, an estimated 68,270 cases of endometrial cancer will be diagnosed in the U.S. in 2026, and approximately 14,450 women will die from the disease. 

Research shows that Black women continue to experience poorer outcomes and are more likely to be diagnosed with aggressive disease subtypes despite historically lower incidence rates than white women. This underscores the need for better risk assessment and earlier interventions to improve outcomes. 

A new study published in the Journal of Racial and Ethnic Health Disparities explored the relationship between altered metabolism and endometrial cancer in Black women. 

Why Metabolic Syndrome Matters in Endometrial Cancer 

Metabolic syndrome is a cluster of five specific health conditions that, when occurring together, significantly raises the risk of heart disease, stroke, and type 2 diabetes. 

A diagnosis of metabolic syndrome is typically made when a patient has at least three of the following five criteria: 

  • Large waist circumference (>35 inches for women) 
  • High triglycerides (≥150 mg/dL (or on medicine to treat high triglycerides) 
  • Low HDL cholesterol (<50 mg/dL for women) 
  • Hypertension (≥130/85 mmHg (or on medicine for high blood pressure) 
  • High fasting blood sugar (≥100 mg/dL (or on medicine for high blood sugar/diabetes) 

Several risk factors can contribute to metabolic syndrome, including: 

  • Insulin resistance 
  • Lifestyle habits (physical inactivity and poor diet) 
  • Age 
  • Genetics 
  • Carrying excess weight 
  • Specific medical conditions, such as sleep apnea, polyendocrine metabolic ovarian syndrome (PMOS), and fatty liver disease 

Metabolic syndrome is a modifiable risk factor associated with both endometrial cancer development and outcomes among survivors. The condition creates an internal environment that encourages cancer cells to grow in the endometrium.  

  • Hormonal imbalance: Excess fat tissue (particularly belly fat) contains aromatase, an enzyme that turns other hormones into estrogen. High estrogen levels without enough progesterone cause the uterine lining to overgrow. 
  • Insulin resistance: Insulin resistance can lead to chronically elevated insulin levels, which function as growth signals that may promote cellular proliferation and tumor development. 
  • Chronic inflammation: Fat tissue releases inflammatory chemicals and alters protective hormones like adiponectin, creating a long-term inflammatory state that damages cells and promotes cancer. 

After a patient has been diagnosed and treated for endometrial cancer, active metabolic syndrome can negatively affect recovery and long-term health. 

Survivors with metabolic syndrome may still face: 

  • Aggressive tumor features 
  • Higher risk of cancer recurrence 
  • Poorer overall survival 

For clinicians, metabolic risk assessment should be considered part of comprehensive cancer prevention efforts in high-risk populations. 

Disproportionate Burden of Aggressive Endometrial Cancer in Black Women 

Rather than evaluating a single patient cohort, the authors conducted a narrative review of existing literature to examine the complex relationship between metabolic dysfunction, endometrial cancer, and health disparities affecting Black women. They found that Black women face a disproportionate increase in aggressive endometrial cancer subtypes and worse clinical outcomes. 

Several factors contribute to these disparities, including: 

  • Delayed diagnosis 
  • Differences in access to specialty care 
  • Structural and social determinants of health 
  • Underrepresentation in research 

For Black women, evidence shows that obesity and metabolic abnormalities are important risk factors for endometrial cancer. Previous research has linked higher body mass index (BMI) and diabetes to increased endometrial cancer risk. 

Additionally, Black women are more likely to be diagnosed with aggressive non-endometrioid histologic subtypes and are more likely to die from endometrial cancer than women from other racial and ethnic groups, making the disease a significant women’s health equity issue. 

Clinicians should be aware that traditional risk models may not fully capture the unique burden of disease faced by Black women. 

chemo-free targeted therapy for metastatic breast cancer
Photo by andreswd/Getty Images

Beyond Biology: The Role of Social Determinants and Healthcare Inequities 

The study’s authors state that the intersection of molecular, clinical, and social determinants of health drives disparities in Black women with endometrial cancer. 

Several barriers can influence outcomes, including: 

  • Access to preventive care 
  • Delayed evaluation of abnormal uterine bleeding 
  • Insurance and socioeconomic barriers 
  • Geographic disparities in gynecologic oncology services 

For Black women, addressing metabolic health alone is insufficient without confronting systemic inequities. Improving outcomes will require both individualized interventions and health-system-level changes. 

Opportunities for Prevention, Early Detection, and Survivorship Care 

The researchers call for improved prevention, detection, treatment, and survivorship strategies for Black women with endometrial cancer. 

Here are some practical approaches clinicians can consider: 

  • Weight management counseling 
  • Diabetes screening and control 
  • Cardiometabolic risk reduction 
  • Prompt evaluation of abnormal uterine bleeding 
  • Survivorship monitoring for metabolic complications 

When caring for patients from marginalized communities, it’s critical for clinicians to deliver culturally responsive care, as it can address severe health disparities, reduce late-stage diagnoses, and combat systemic mistreatment that drives a mortality rate nearly double that of white women. 

Earlier intervention on metabolic health may offer opportunities to reduce both cancer risk and adverse outcomes. However, the authors emphasize that meaningful progress will require addressing both biological risk factors and the structural inequities that continue to contribute to delayed diagnoses, treatment disparities, and poorer survival among Black women with endometrial cancer. 

AI-Powered Search. Human-Created Content.

What is the biggest opportunity for human-based research in advancing biomedical science?

What is the biggest opportunity for human-based research in advancing biomedical science?

Expert Medical Insights, Straight to Your Inbox

Insights That Keep Black Healthcare Leaders at the Forefront

By subscribing, you consent to receive emails from BlackDoctor.pro You may unsubscribe at any time. Privacy Policy & Terms of Service.

Top Articles

Empowering Culturally-Sensitive Healthcare Professionals

BlackDoctor Pro is an online destination created specifically for Black doctors and culturally-sensitive healthcare professionals. Our platform delivers trusted, relevant, and timely medical content, including in-depth articles, the latest treatment updates, healthcare policy, and emerging clinical studies. We are committed to empowering HCPs with the knowledge, resources, and support needed to achieve exceptional health outcomes in black communities.
Copyright © 2026, BlackDoctor, Inc. All rights reserved.
BlackDoctor Pro is an online destination created specifically for Black doctors and other culturally-sensitive healthcare professionals. Our platform delivers trusted, relevant, and timely medical content, including in-depth articles, the latest treatment updates, healthcare policy, and emerging clinical studies.
AI-Powered Search. Human-Created Content.